Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1646 per EA under NDC 62332010231. Its NADAC has been published 477 times since Jul 5, 2017.
FDA first approved this application on Apr 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332010231
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202101FDA Approved
4/28/2015
TE Code
AB
On Market Since
7/7/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 477 times since Jul 5, 2017, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1646 per EA |
|---|---|
| All-time high | $1.2341 (Jul 12, 2017) |
| All-time low | $0.1365 (Nov 20, 2024) |
| 52-week high | $0.1764 |
| 52-week low | $0.1567 |
| Median price | $0.2793 |
| Average price | $0.3614 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 477 |
| Tracking since | Jul 5, 2017 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1646 per EA (NDC 62332010231), effective Aug 19, 2026.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 86.7%. It has been tracked across 477 weekly CMS publications since Jul 5, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Jul 5, 2017, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $1.2341 (Jul 12, 2017), with a median of $0.2793 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 62332010231) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.